Atika Capital Management LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Atika Capital Management LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,596,000
+47.1%
100,000
+316.7%
0.48%
+11.0%
Q2 2022$3,804,000
+74.5%
24,000
-20.0%
0.43%
+132.6%
Q1 2022$2,180,000
-78.3%
30,000
+3429.4%
0.18%
-73.9%
Q4 2021$10,050,000
+17.1%
850
-98.7%
0.70%
+38.0%
Q3 2021$8,586,000
-15.8%
64,000
+1.6%
0.51%
-36.4%
Q2 2021$10,200,00063,0000.80%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders